NCT01816152 is a NA clinical trial of Tailored Active intervention in Sleep Disturbances, sponsored by Icahn School of Medicine at Mount Sinai.

Who is sponsoring NCT01816152?

NCT01816152 is sponsored by Icahn School of Medicine at Mount Sinai.

What drugs are being tested in NCT01816152?

Interventions in NCT01816152: Tailored Active intervention, Inactive intervention.

What condition does NCT01816152 study?

NCT01816152 studies Sleep Disturbances, Depression.

Is NCT01816152 still recruiting?

NCT01816152 is currently completed. Last updated 4 June 2024.

Last reviewed 2024-06-04 · How we verify

NCT01816152

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Methodology Issues in a Tailored Light Treatment for Persons With Dementia

Completed NA Last updated 4 June 2024

What this trial tests

NA trial testing Tailored Active intervention in Sleep Disturbances in 45 participants. Completed in 10 May 2024.

Timeline

1 January 2020

Primary endpoint
10 May 2024

10 May 2024

Quick facts

Lead sponsor	Icahn School of Medicine at Mount Sinai
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	treatment
Enrollment	45
Start date	1 January 2020
Primary completion	10 May 2024
Estimated completion	10 May 2024
Sites	2 locations across United States

Drugs / interventions tested

Tailored Active intervention
Inactive intervention

Conditions studied

Sleep Disturbances — all drugs for Sleep Disturbances →
Depression — all drugs for Depression →

Sponsor

Icahn School of Medicine at Mount Sinai

Who can join

65 and older, any sex, with Sleep Disturbances or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alzheimer's disease and related dementia

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia.
Forbes D, Blake CM, Thiessen EJ, Peacock S, et al · · 2014 · cited 104× · PMID 24574061 · DOI 10.1002/14651858.cd003946.pub4
Effects of a Tailored Lighting Intervention on Sleep Quality, Rest-Activity, Mood, and Behavior in Older Adults With Alzheimer Disease and Related Dementias: A Randomized Clinical Trial.
Figueiro MG, Plitnick B, Roohan C, Sahin L, et al · · 2019 · cited 73× · PMID 31855161 · DOI 10.5664/jcsm.8078
Non-pharmacological interventions for sleep disturbances in people with dementia.
Wilfling D, Calo S, Dichter MN, Meyer G, et al · · 2023 · cited 34× · PMID 36594432 · DOI 10.1002/14651858.cd011881.pub2
Long-Term, All-Day Exposure to Circadian-Effective Light Improves Sleep, Mood, and Behavior in Persons with Dementia.
Figueiro MG, Sahin L, Kalsher M, Plitnick B, et al · · 2020 · cited 26× · PMID 33024938 · DOI 10.3233/adr-200212

Verify or expand the search:

Other recruiting trials for Sleep Disturbances

Currently open trials in the same condition.

NCT06754722 — Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors · NA · recruiting
NCT07122921 — Cross-sectional Study of Sleep Disturbance in Hong Kong Children With Cancer Comparing With Healthy Counterparts and Chi · recruiting
NCT07179172 — Neurobiological Investigations of Mindfulness, Depression and Sleep Disturbances in Medical Staffs and Community Elders · NA · recruiting
NCT06776705 — Low-intensity TUS for Sleep Disturbances in Patients With Chronic Tinnitus · NA · recruiting
NCT05234125 — Better Lifestyle Counseling for African American Women During Pregnancy · NA · recruiting

Other Icahn School of Medicine at Mount Sinai trials

Trials by the same sponsor.

NCT07094308 — The LIFT-ECHO Last Mile Project · NA · not yet recruiting
NCT07291427 — Chronic Subdural Hematoma Embolization With Detachable Coils · not yet recruiting
NCT07194187 — High Intensity Focused Ultrasound (HIFU) Ablation for Treatment of Prostate Tissue in Bladder Outlet Obstruction · NA · not yet recruiting
NCT07260916 — Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation · NA · not yet recruiting
NCT07487948 — Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01816152 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai
Last refreshed: 4 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01816152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing